Nigeria Launches First Cancer Immunotherapy Trial in Sub-Saharan Africa

A historic medical milestone just unfolded in Nigeria. Obafemi Awolowo University and Lagos University Teaching Hospital have partnered with Memorial Sloan Kettering Cancer Center to launch the region’s first cancer immunotherapy trial. Immunotherapy represents a major leap in cancer care by empowering the body’s own defenses instead of relying solely on traditional treatments. This development challenges the notion that cutting-edge breakthroughs only happen abroad. While obstacles like healthcare access and brain drain remain, this achievement proves that Nigerian institutions have the capacity for world-class research. Could this be the turning point for advanced treatment developed at home?

Use The App To Win ₦1m

Stories are shared by community members. This article does not represent the official view of NaijaWorld — the author is solely responsible for its content.